Patents by Inventor Roberto De Noni

Roberto De Noni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9889153
    Abstract: Electrolytic acid or alkaline water having a NMR half line width using 170 of from about 45 to less than 51 Hz, and an oxide reduction potential of from ?1000 to +200 mV, or from +600 to +1300 mV, topical compositions that contain such water, uses for such water to hydrate skin, deliver drugs and treat various skin and mucosal conditions, and methods and apparatus for manufacturing the water.
    Type: Grant
    Filed: July 19, 2016
    Date of Patent: February 13, 2018
    Assignee: APR NANOTECHNOLOGIES s.a.
    Inventors: Yongge Chen, Roberto De Noni
  • Publication number: 20160324889
    Abstract: Electrolytic acid or alkaline water having a NMR half line width using 170 of from about 45 to less than 51 Hz, and an oxide reduction potential of from ?1000 to +200 mV, or from +600 to +1300 mV, topical compositions that contain such water, uses for such water to hydrate skin, deliver drugs and treat various skin and mucosal conditions, and methods and apparatus for manufacturing the water.
    Type: Application
    Filed: July 19, 2016
    Publication date: November 10, 2016
    Applicant: APR NANOTECHNOLOGIES s.a.
    Inventors: Yongge CHEN, Roberto DE NONI
  • Publication number: 20160324891
    Abstract: The present invention relates to methods of treating or preventing an infection or infectious disease in a mammal, or sanitizing mammalian tissue, or treating or preventing psoriasis in a mammal, comprising topically administering to said mammal an electrolytic acid water comprising free chlorine, wherein: a) from 90% to 99.9% of said free chlorine is present in the form of hypochlorous acid; b) said water has a pH of from 0.5 to 5.0; and c) said water has oxidation reduction potential (ORP) of greater than 1100 mV. The present invention also relates to methods of healing, repair or regeneration of a tissue in a mammal comprising topically administering to said tissue said electrolytic acid water.
    Type: Application
    Filed: July 22, 2016
    Publication date: November 10, 2016
    Applicant: APR NANOTECHNOLOGIES s.a.
    Inventors: Yongge CHEN, Roberto DE NONI, Giorgio REINER
  • Patent number: 9404192
    Abstract: Electrolytic acid or alkaline water having a NMR half line width using 17O of from about 45 to less than 51 Hz, and an oxide reduction potential of from ?1000 to +200 mV, or from +600 to +1300 mV, topical compositions that contain such water, uses for such water to hydrate skin, deliver drugs and treat various skin and mucosal conditions, and methods and apparatus for manufacturing the water.
    Type: Grant
    Filed: March 4, 2014
    Date of Patent: August 2, 2016
    Assignee: APR NANOTECHNOLOGIES s.a.
    Inventors: Yongge Chen, Roberto De Noni
  • Publication number: 20140294992
    Abstract: Electrolytic acid or alkaline water having a NMR half line width using 17O of from about 45 to less than 51 Hz, and an oxide reduction potential of from ?1000 to +200 mV, or from +600 to +1300 mV, topical compositions that contain such water, uses for such water to hydrate skin, deliver drugs and treat various skin and mucosal conditions, and methods and apparatus for manufacturing the water.
    Type: Application
    Filed: March 4, 2014
    Publication date: October 2, 2014
    Applicant: APR NANOTECHNOLOGIES s.a.
    Inventors: Yongge Chen, Roberto De Noni
  • Publication number: 20140178500
    Abstract: The present invention relates to a method of treating an outer eye disorder selected from a cataract, neovascularization, keratitis, epithelium deficiency, or chronic opacity, by administering to the eye a composition comprising acidic electrolytic water. The present invention also relates to a stable acidic electrolyzed oxidizing water characterized by low conductivity, the presence of dissolved chlorine gas (Cl2), hypochlorous acid (HOCl) and chloride ions (Cl?), and by the presence of negligible quantities of hypochlorite ion (OCl?).
    Type: Application
    Filed: February 27, 2014
    Publication date: June 26, 2014
    Applicant: APR Nanotechnologies s.a.
    Inventors: Yongge Chen, Roberto De Noni
  • Patent number: 8709495
    Abstract: Electrolytic acid or alkaline water having a NMR half line width using 17O of from about 45 to less than 51 Hz, and an oxide reduction potential of from ?1000 to +200 mV, or from +600 to +1300 mV, topical compositions that contain such water, uses for such water to hydrate skin, deliver drugs and treat various skin and mucosal conditions, and methods and apparatus for manufacturing the water.
    Type: Grant
    Filed: April 25, 2008
    Date of Patent: April 29, 2014
    Assignee: APR Nanotechnologies S.A.
    Inventors: Yongge Chen, Roberto De Noni
  • Patent number: 8691289
    Abstract: The present invention relates to a method of treating an outer eye disorder selected from a cataract, neovascularization, keratitis, epithelium deficiency, or chronic opacity, by administering to the eye a composition comprising acidic electrolytic water. The present invention also relates to a stable acidic electrolyzed oxidizing water characterized by low conductivity, the presence of dissolved chlorine gas (Cl2), hypochlorous acid (HOCl) and chloride ions (Cl?), and by the presence of negligible quantities of hypochlorite ion (OCl?).
    Type: Grant
    Filed: June 16, 2010
    Date of Patent: April 8, 2014
    Assignee: APR Nanotechnologies S.A.
    Inventors: Yongge Chen, Roberto De Noni
  • Publication number: 20130259955
    Abstract: The present invention relates to methods of treating or preventing an infection or infectious disease in a mammal, or sanitizing mammalian tissue, or treating or preventing psoriasis in a mammal, comprising topically administering to said mammal an electrolytic acid water comprising free chlorine, wherein: a) from 90% to 99.9% of said free chlorine is present in the form of hypochlorous acid; b) said water has a pH of from 0.5 to 5.0; and c) said water has oxidation reduction potential (ORP) of greater than 1100 mV. The present invention also relates to methods of healing, repair or regeneration of a tissue in a mammal comprising topically administering to said tissue said electrolytic acid water.
    Type: Application
    Filed: February 15, 2013
    Publication date: October 3, 2013
    Applicant: APR Nanotechnologies s.a.
    Inventors: Yongge Chen, Roberto De Noni, Giorgio Reiner, Paolo Galfetti
  • Publication number: 20130224314
    Abstract: The present invention relates to methods of treating or preventing an infection or infectious disease in a mammal, or sanitizing mammalian tissue, or treating or preventing psoriasis in a mammal, comprising topically administering to said mammal an electrolytic acid water comprising free chlorine, wherein: a) from 90% to 99.9% of said free chlorine is present in the form of hypochlorous acid; b) said water has a pH of from 0.5 to 5.0; and c) said water has oxidation reduction potential (ORP) of greater than 1100 mV. The present invention also relates to methods of healing, repair or regeneration of a tissue in a mammal comprising topically administering to said tissue said electrolytic acid water.
    Type: Application
    Filed: February 15, 2013
    Publication date: August 29, 2013
    Applicant: APR Nanotechnologies s.a.
    Inventors: Yongge Chen, Roberto De Noni, Giorgio Reiner, Paolo Galfetti
  • Patent number: 8277634
    Abstract: A highly stable aqueous solution having a molecular cluster with dimensions which are small enough to ensure substantial chemical-physical stability thereof for a relatively long time. To prepare the solution a fluid treatment device is used, which comprises at least one chamber (7) and at least one anode (4) and one cathode (3) arranged in the chamber (7). The anode (4) and cathode (3) are at least partly made of a first metallic material. At least one of the at least one cathode (3) and anode (4) comprises a coating of nanoparticles (5) of a second metallic material.
    Type: Grant
    Filed: October 23, 2006
    Date of Patent: October 2, 2012
    Assignee: APR Nanotechnologies S.A.
    Inventors: Yongge Chen, Roberto De Noni
  • Publication number: 20120156307
    Abstract: The present invention relates to methods of treating or preventing an infection or infectious disease in a mammal, or sanitizing mammalian tissue, or treating or preventing psoriasis in a mammal, comprising topically administering to said mammal an electrolytic acid water comprising free chlorine, wherein: a) from 90% to 99.9% of said free chlorine is present in the form of hypochlorous acid; b) said water has a pH of from 0.5 to 5.0; and c) said water has oxidation reduction potential (ORP) of greater than 1100 mV. The present invention also relates to methods of healing, repair or regeneration of a tissue in a mammal comprising topically administering to said tissue said electrolytic acid water.
    Type: Application
    Filed: December 13, 2011
    Publication date: June 21, 2012
    Applicant: APR Nanotechnologies s.a.
    Inventors: Yongge Chen, Roberto De Noni, Giorgio Reiner, Paolo Galfetti
  • Publication number: 20100330204
    Abstract: The present invention relates to a method of treating an outer eye disorder selected from a cataract, neovascularization, keratitis, epithelium deficiency, or chronic opacity, by administering to the eye a composition comprising acidic electrolytic water. The present invention also relates to a stable acidic electrolyzed oxidizing water characterized by low conductivity, the presence of dissolved chlorine gas (Cl2), hypochlorous acid (HOCl) and chloride ions (Cl?), and by the presence of negligible quantities of hypochlorite ion (OCl?).
    Type: Application
    Filed: June 16, 2010
    Publication date: December 30, 2010
    Applicant: APR NANOTECHNOLOGIES S.A.
    Inventors: Yongge CHEN, Roberto DE NONI
  • Publication number: 20100119616
    Abstract: Electrolytic acid or alkaline water having a NMR half line width using 17O of from about 45 to less than 51 Hz, and an oxide reduction potential of from ?1000 to +200 mV, or from +600 to +1300 mV, topical compositions that contain such water, uses for such water to hydrate skin, deliver drugs and treat various skin and mucosal conditions, and methods and apparatus for manufacturing the water.
    Type: Application
    Filed: April 25, 2008
    Publication date: May 13, 2010
    Applicant: Akuatech S.R.L.
    Inventors: Yongge Chen, Roberto De Noni
  • Publication number: 20080292717
    Abstract: A highly stable aqueous solution having a molecular cluster with dimensions which are small enough to ensure substantial chemical-physical stability thereof for a relatively long time. To prepare the solution a fluid treatment device is used, which comprises at least one chamber (7) and at least one anode (4) and one cathode (3) arranged in the chamber (7). The anode (4) and cathode (3) are at least partly made of a first metallic material. At least one of the at least one cathode (3) and anode (4) comprises a coating of nanoparticles (5) of a second metallic material.
    Type: Application
    Filed: October 23, 2006
    Publication date: November 27, 2008
    Applicant: AKUATECH S.R.L.
    Inventors: Yongge Chen, Roberto De Noni